ES8801785A1 - Un procedimiento para la preparacion de nuevas azetidinonas sustituidas. - Google Patents
Un procedimiento para la preparacion de nuevas azetidinonas sustituidas.Info
- Publication number
- ES8801785A1 ES8801785A1 ES553821A ES553821A ES8801785A1 ES 8801785 A1 ES8801785 A1 ES 8801785A1 ES 553821 A ES553821 A ES 553821A ES 553821 A ES553821 A ES 553821A ES 8801785 A1 ES8801785 A1 ES 8801785A1
- Authority
- ES
- Spain
- Prior art keywords
- inflammatory
- antidegenerative
- medicaments
- manufacture
- pharmaceutical compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE AZETIDINONAS SUSTITUIDAS DE FORMULA (I). COMPRENDE LA REACCION DE UN COMPUESTO DE FORMULA (II) CON ISOCIANATO DE CLOROSULFONILO, SEGUIDA DEL TRATAMIENTO DEL COMPUESTO FORMADO CON UN COMPUESTO DE FORMULA AX O A2O, PARA OBTENER UN COMPUESTO DE FORMULA (I), EN LAS QUE X REPRESENTA UN ATOMO DE HALOGENO, Y A, R, R1, R2 Y R3 PUEDEN SER VARIOS TIPOS DE RADICALES. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO AGENTES ANTIINFLAMATORIOS Y ANTIDEGENERATIVOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/721,811 US4680391A (en) | 1983-12-01 | 1985-04-10 | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
Publications (2)
Publication Number | Publication Date |
---|---|
ES553821A0 ES553821A0 (es) | 1988-02-16 |
ES8801785A1 true ES8801785A1 (es) | 1988-02-16 |
Family
ID=24899403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES553821A Expired ES8801785A1 (es) | 1985-04-10 | 1986-04-09 | Un procedimiento para la preparacion de nuevas azetidinonas sustituidas. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4680391A (es) |
EP (1) | EP0199630B1 (es) |
JP (1) | JPS61289074A (es) |
AT (1) | ATE56703T1 (es) |
CA (1) | CA1286304C (es) |
DE (1) | DE3674237D1 (es) |
DK (1) | DK159386A (es) |
ES (1) | ES8801785A1 (es) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5229510A (en) * | 1983-12-01 | 1993-07-20 | Merck & Co., Inc. | β-lactams useful in determining the amount of elastase in a clinical sample |
US5229381A (en) * | 1983-12-01 | 1993-07-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
FR2572727B1 (fr) * | 1984-11-02 | 1989-05-19 | Roussel Uclaf | Nouveau procede de preparation de 2-azetidinones optiquement actives, produits intermediaires de ce procede et produits finals obtenus par le procede |
IL89835A0 (en) * | 1988-04-11 | 1989-12-15 | Merck & Co Inc | Substituted azetidinones,their preparation and pharmaceutical compositions containing them |
FR2640621B1 (fr) * | 1988-12-19 | 1992-10-30 | Centre Nat Rech Scient | N-aryl-azetidinones, leur procede de preparation et leur utilisation comme inhibiteurs des elastases |
MY110249A (en) * | 1989-05-31 | 1998-03-31 | Univ Florida State | Method for preparation of taxol using beta lactam |
US4983597A (en) * | 1989-08-31 | 1991-01-08 | Merck & Co., Inc. | Beta-lactams as anticholesterolemic agents |
US5175283A (en) * | 1990-06-04 | 1992-12-29 | Bristol-Myers Squibb Company | Azetidin-2-one derivatives as serine protease inhibitors |
US5250677A (en) * | 1990-06-04 | 1993-10-05 | Bristol-Myers Squibb Company | Azetidin-2-one derivatives as serine protease inhibitors |
US5110812A (en) * | 1990-06-04 | 1992-05-05 | Bristol-Myers Squibb Co. | Azetidin-2-one derivatives as serine protease inhibitors |
US5037819A (en) * | 1990-06-04 | 1991-08-06 | Bristol-Myers Squibb Company | Azetidin-2-one derivatives as serine protease inhibitors |
US5120729A (en) * | 1990-06-20 | 1992-06-09 | Merck & Co., Inc. | Beta-lactams as antihypercholesterolemics |
IL99658A0 (en) * | 1990-10-15 | 1992-08-18 | Merck & Co Inc | Substituted azetidinones and pharmaceutical compositions containing them |
GB9103654D0 (en) * | 1991-02-21 | 1991-04-10 | Merck Sharp & Dohme | Chemical process |
US5104862A (en) * | 1991-03-20 | 1992-04-14 | Merck & Co., Inc. | Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
US5100880A (en) * | 1991-03-20 | 1992-03-31 | Merck & Co., Inc. | Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
US5348953A (en) * | 1991-06-25 | 1994-09-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
WO1993000332A1 (en) * | 1991-06-25 | 1993-01-07 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
CZ14294A3 (en) * | 1991-07-23 | 1994-07-13 | Schering Corp | Substituted beta-lactam compounds usable as hypocholesterol pharmaceutical preparations and process for preparing thereof |
US5688787A (en) * | 1991-07-23 | 1997-11-18 | Schering Corporation | Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof |
US5688785A (en) * | 1991-07-23 | 1997-11-18 | Schering Corporation | Substituted azetidinone compounds useful as hypocholesterolemic agents |
US5229267A (en) * | 1991-08-26 | 1993-07-20 | Merck & Co., Inc. | Assay for evaluating inhibition of PMN elastase by N-substituted azetidinones |
US5274080A (en) * | 1991-08-26 | 1993-12-28 | Merck & Co., Inc. | Monospecific antibodies useful in evaluating inhibition of polymorphonuclear leukocyte elastase by N-substituted azetidinones |
US5276139A (en) * | 1991-08-26 | 1994-01-04 | Merck & Co., Inc. | Haptens useful in evaluating inhibition of PNN elastase by N-substituted azetidinones |
US5149838A (en) * | 1991-09-20 | 1992-09-22 | Merck & Co., Inc. | Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents |
US5739362A (en) * | 1991-09-23 | 1998-04-14 | Florida State University | Taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them |
US5710287A (en) * | 1991-09-23 | 1998-01-20 | Florida State University | Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them |
US6794523B2 (en) | 1991-09-23 | 2004-09-21 | Florida State University | Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them |
US5284865A (en) * | 1991-09-23 | 1994-02-08 | Holton Robert A | Cyclohexyl substituted taxanes and pharmaceutical compositions containing them |
US6005138A (en) | 1991-09-23 | 1999-12-21 | Florida State University | Tricyclic taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them |
US6018073A (en) * | 1991-09-23 | 2000-01-25 | Florida State University | Tricyclic taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them |
US6335362B1 (en) * | 1991-09-23 | 2002-01-01 | Florida State University | Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them |
US5728850A (en) * | 1991-09-23 | 1998-03-17 | Florida State University | Taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them |
US5489601A (en) * | 1991-09-23 | 1996-02-06 | Florida State University | Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them |
CA2147129A1 (en) * | 1992-10-27 | 1994-05-11 | James B. Doherty | New substituted azetidinones as anti-inflammatory and antidegenerative agents |
ATE249826T1 (de) * | 1992-11-13 | 2003-10-15 | Univ Florida State | Isobutenyl-substituierte taxane und deren pharmazeutische zusammensetzungen |
WO1994013636A1 (en) * | 1992-12-17 | 1994-06-23 | Merck & Co., Inc. | New substituted azetidinones as anti-inflammatory and antidegenerative agents |
US5591737A (en) * | 1992-12-17 | 1997-01-07 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
LT3300B (en) * | 1992-12-23 | 1995-06-26 | Schering Corp | Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor |
TW467896B (en) | 1993-03-19 | 2001-12-11 | Bristol Myers Squibb Co | Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes |
GB9314350D0 (en) * | 1993-07-12 | 1993-08-25 | Zeneca Ltd | Armide derivatives |
US5420010A (en) * | 1993-07-30 | 1995-05-30 | Merck & Co., Inc. | Assay for evaluating inhibition of polymorphonuclear leukocyte elastase by N-substituted azetidinones |
US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
US5627176A (en) * | 1994-03-25 | 1997-05-06 | Schering Corporation | Substituted azetidinone compounds useful as hypocholesterolemic agents |
US5624920A (en) * | 1994-11-18 | 1997-04-29 | Schering Corporation | Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
US5633246A (en) * | 1994-11-18 | 1997-05-27 | Schering Corporation | Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
US5656624A (en) * | 1994-12-21 | 1997-08-12 | Schering Corporation | 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
AP9701007A0 (en) * | 1994-12-22 | 1997-07-31 | Smithkline Beecham Plc | Substituted azetidin-2-ones for treatment of atherosclerosis. |
US5747485A (en) * | 1995-04-13 | 1998-05-05 | Merck & Co., Inc. | Substituted azetidiones as anti-inflammatory and antidegenerative agents |
TR199701762T1 (xx) * | 1995-07-01 | 1998-05-21 | Smithkline Beecham P.L.C. | Damar t�kanmas� tedavisi i�in azetidinon t�revleri. |
AU7222196A (en) * | 1995-10-09 | 1997-04-30 | Chiroscience Limited | Azetidinones and their therapeutic use as cytokine inhibitors |
EP0869943A1 (en) * | 1995-12-08 | 1998-10-14 | Smithkline Beecham Plc | Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
JP2000505063A (ja) * | 1995-12-08 | 2000-04-25 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | アテローム性動脈硬化症の治療のためのアゼチジノン化合物 |
BR9709196A (pt) * | 1996-04-26 | 1999-05-25 | Smithkline Beecham Plc | Derivados de azetidinona para o tratamento de aterosclerose |
GB9608649D0 (en) * | 1996-04-26 | 1996-07-03 | Smithkline Beecham Plc | Novel compounds |
AU724499B2 (en) * | 1996-05-06 | 2000-09-21 | Florida State University | 1-deoxy baccatin III, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof |
US5756470A (en) * | 1996-10-29 | 1998-05-26 | Schering Corporation | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
EP1021405B1 (en) | 1997-10-07 | 2002-09-25 | Boehringer Ingelheim (Canada) Ltd. | Azetidinone derivatives for the treatment of hcmv infections |
PT1021404E (pt) | 1997-10-07 | 2003-04-30 | Boehringer Ingelheim Ca Ltd | Derivados de azetidinona para o tratamento de infeccoes pelo hcmv |
JP2001519330A (ja) * | 1997-10-07 | 2001-10-23 | ベーリンガー インゲルハイム (カナダ) リミテッド | Hcmv感染の治療に用いるアゼチジノン誘導体 |
US6335324B1 (en) | 1998-06-25 | 2002-01-01 | Bristol-Myers Squibb Co. | Beta lactam compounds and their use as inhibitors of tryptase |
WO2000063703A1 (en) * | 1999-04-16 | 2000-10-26 | Schering Corporation | Use of azetidinone compounds |
US6982251B2 (en) * | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
EP1671650A1 (en) * | 2001-01-26 | 2006-06-21 | Schering Corporation | Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications |
PE20020850A1 (es) * | 2001-01-26 | 2002-09-21 | Schering Corp | Utilizacion de compuestos de azetidinona sustituida para tratamiento de la sitosterolemia |
HUP0303917A2 (hu) * | 2001-01-26 | 2004-03-01 | Schering Corporation | Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére |
US7071181B2 (en) * | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
AR035739A1 (es) * | 2001-01-26 | 2004-07-07 | Schering Corp | Composiciones farmaceuticas y combinaciones terapeuticas que comprenden secuestrante (s) de los acidos biliares y de inhibidor (es) de la absorcion de los esteroles y el uso de dichas composiciones para la manufactura de un medicamento para el tratamiento de indicaciones vasculares |
SK287988B6 (sk) * | 2001-01-26 | 2012-09-03 | Schering Corporation | Composition, oral dosage form and use thereof |
ES2286233T3 (es) * | 2001-01-26 | 2007-12-01 | Schering Corporation | Combinaciones de inhibidor(es) de la absorcion de esteroles con agente(s) cardiovascular(es) para el tratamiento de afecciones vasculares. |
CN1275949C (zh) | 2001-03-28 | 2006-09-20 | 先灵公司 | 2-吖丁啶酮中间体化合物的对映体选择性合成 |
JP2004532868A (ja) * | 2001-05-25 | 2004-10-28 | シェーリング コーポレイション | アルツハイマー病の処置におけるアゼチジノン置換誘導体の使用 |
US20030119808A1 (en) * | 2001-09-21 | 2003-06-26 | Schering Corporation | Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects |
JP4395370B2 (ja) * | 2001-09-21 | 2010-01-06 | シェーリング コーポレイション | ステロール吸収阻害剤を使用して血管炎症を治療または予防する方法 |
US7053080B2 (en) * | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
US7056906B2 (en) * | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
MXPA04002573A (es) * | 2001-09-21 | 2004-06-18 | Schering Corp | Tratamiento de xantoma con derivados de azetidinona como inhibidores de la absorcion de esterol. |
CN1596250A (zh) * | 2001-11-30 | 2005-03-16 | 布里斯托尔-迈尔斯斯奎布公司 | 紫杉醇溶剂化物 |
WO2004043457A1 (en) * | 2002-11-06 | 2004-05-27 | Schering Corporation | Cholesterol absorptions inhibitors for the treatment of autoimmune disorders |
ATE406364T1 (de) | 2003-03-07 | 2008-09-15 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
JP4589919B2 (ja) | 2003-03-07 | 2010-12-01 | シェーリング コーポレイション | 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用 |
US7192944B2 (en) * | 2003-03-07 | 2007-03-20 | Schering Corp. | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
CA2544309A1 (en) * | 2003-11-05 | 2005-05-26 | Schering Corporation | Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions |
CN101029056B (zh) * | 2006-02-28 | 2011-06-08 | 天津国韵生物材料有限公司 | 聚-3-羟基丁酸酯在制备β-内酰胺化合物中的用途 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1906401A1 (de) * | 1969-02-08 | 1970-08-27 | Hoechst Ag | Verfahren zur Herstellung von 4-Acyloxy-azetidin-2-onen |
BE755940A (fr) * | 1969-09-09 | 1971-03-09 | Hoechst Ag | Azetidinones-2 portant des substituants en position 4 et leur preparation |
DE2046823A1 (de) * | 1970-09-23 | 1972-03-30 | Farbwerke Hoechst AG vormals Meister Lucius & Brüning, 6000 Frankfurt | Neue Azetidinone-(2) und Verfahren zu deren Herstellung |
DE2046822A1 (de) * | 1970-09-23 | 1972-03-30 | Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt | Neue Azetidinone-(2) und Verfahren zu deren Herstellung |
US4064120A (en) * | 1976-11-01 | 1977-12-20 | E. R. Squibb & Sons, Inc. | 3,3-Dichloro-2-azetidinone derivatives having antiinflammatory activity |
LU77306A1 (es) * | 1977-05-09 | 1979-01-18 | ||
US4115382A (en) * | 1977-06-06 | 1978-09-19 | E. R. Squibb & Sons, Inc. | 3,3-Dichloro-2-azetidinone derivatives having basic substituents |
GB2006195B (en) * | 1977-09-30 | 1982-03-17 | Kyowa Hakko Kogyo Kk | 2-azetidinone derivatives |
EP0042026B1 (de) * | 1978-02-02 | 1986-01-08 | Ciba-Geigy Ag | 3,4-Disubstituierte Azetidin-2-onverbindungen und Verfahren zu ihrer Herstellung |
US4174317A (en) * | 1978-03-24 | 1979-11-13 | E. R. Squibb & Sons, Inc. | 3,3-Dichloro-2-azetidinone derivatives |
AT365594B (de) * | 1978-11-24 | 1982-01-25 | Erba Farmitalia | Verfahren zur herstellung von neuen 7-oxo-4-thia1-aza-bicyclo-(3,2,0)heptanderivaten |
DE3007298A1 (de) * | 1980-02-27 | 1981-09-03 | Merck Patent Gmbh, 6100 Darmstadt | Verfahren zur herstellung von azetidinonen und deren verwendung |
HU181742B (en) * | 1980-09-15 | 1983-11-28 | Richter Gedeon Vegyeszet | Process for producing new azetidinone derivatives |
EP0051813B1 (en) * | 1980-11-06 | 1986-07-30 | Hoechst Uk Limited | 7-oxo-4-thia-1-aza(3,2,0)heptane and 7-oxo-4-thia-1-aza(3,2,0)hept-2-ene derivatives |
WO1982001873A1 (en) * | 1980-12-05 | 1982-06-10 | Takeda Chemical Industries Ltd | 1-sulfo-2-oxoazetidine derivatives and process for their preparation |
JPS5857360A (ja) * | 1981-10-01 | 1983-04-05 | Ajinomoto Co Inc | アゼチジノン誘導体 |
US4493839A (en) * | 1982-05-24 | 1985-01-15 | Merck & Co., Inc. | 1-Carbapenem-3-carboxylic esters as anti-inflammatory agents |
-
1985
- 1985-04-10 US US06/721,811 patent/US4680391A/en not_active Expired - Fee Related
-
1986
- 1986-04-04 CA CA000505856A patent/CA1286304C/en not_active Expired - Fee Related
- 1986-04-08 EP EP86400751A patent/EP0199630B1/en not_active Expired - Lifetime
- 1986-04-08 AT AT86400751T patent/ATE56703T1/de not_active IP Right Cessation
- 1986-04-08 DE DE8686400751T patent/DE3674237D1/de not_active Expired - Fee Related
- 1986-04-09 DK DK159386A patent/DK159386A/da not_active Application Discontinuation
- 1986-04-09 ES ES553821A patent/ES8801785A1/es not_active Expired
- 1986-04-10 JP JP61081231A patent/JPS61289074A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DK159386D0 (da) | 1986-04-09 |
ATE56703T1 (de) | 1990-10-15 |
DE3674237D1 (de) | 1990-10-25 |
EP0199630B1 (en) | 1990-09-19 |
EP0199630A1 (en) | 1986-10-29 |
ES553821A0 (es) | 1988-02-16 |
US4680391A (en) | 1987-07-14 |
CA1286304C (en) | 1991-07-16 |
DK159386A (da) | 1986-10-11 |
JPS61289074A (ja) | 1986-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8801785A1 (es) | Un procedimiento para la preparacion de nuevas azetidinonas sustituidas. | |
IL89835A0 (en) | Substituted azetidinones,their preparation and pharmaceutical compositions containing them | |
JO1502B1 (en) | New pharmacy vehicles | |
YU57600A (sh) | Derivarti biciklične hidroksaminske kiseline | |
IT1197592B (it) | Derivati di 3-cheto delta 4,9 19-nor-steroidi,procedimento per la loro preparazione,loro impiego come medicamenti,composizioni che li contengono ed intermedi ottenuti | |
ZA874635B (en) | Novel anti-inflammatory agents,pharmaceutical compositions and methods for reducing inflammation | |
IT1214609B (it) | Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono. | |
ATE22562T1 (de) | 6-substituierte s-triazolo(3,4-a)phthalazinderivate. | |
EP0279149A3 (en) | Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same | |
IL84359A0 (en) | Substituted cephalosporin sulfones,their preparation and pharmaceutical compositions containing them | |
IT1203791B (it) | Derivati del morfinano e della morfina,loro preparazione,loro impiego come medicamenti e e le composizioni farmaceutiche che li contengono | |
JO1406B1 (en) | Chemical compounds | |
IL79642A0 (en) | Benzimidazole derivatives,their manufacture and pharmaceutical compositions containing them | |
AU6697786A (en) | New derivatives of 1-sulphonyl 2-oxo-5-alkoxy pyrrolidine, their preparation process, their use as medicaments and the compositions containing them | |
MY128261A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
SE8405588D0 (sv) | New compounds | |
IT1190401B (it) | Derivati di vitamina d,composizioni farmaceutiche che li contengono e loro precursori | |
IT1227456B (it) | Nuovi alcossi derivati di ginkgolidi, loro preparazione e composizioni terapeutiche che li contengono | |
PH21556A (en) | Phenyl nonatetraenoic acid derivatives, pharmaceutical compositions containing the same and method of use thereof | |
FR2575159B1 (fr) | Nouvelles 8a-acylaminoergolines, leur preparation, leur utilisation comme medicaments et les compositions pharmaceutiques les contenant | |
FI862566A (fi) | Foerfarande foer framstaellning av nya penemderivat. | |
IT1235761B (it) | Derivati biciclici del catecolo, procedimento per la loro preparazione e composizioni terapeutiche che li contengono | |
IT1196494B (it) | Derivati dell'acito cef-3-em-4-carbossilico,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
AU6740187A (en) | Heterocyclic compounds, methods for the manufacture of the same and pharmaceutical compositions containing the same | |
IT8520515A0 (it) | Composizioni di farmaci eprocedimento per la loro preparazione. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19970519 |